These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. COMP-structure-based design and development of estrogen receptor modulators. Rotella D IDrugs; 2006 Nov; 9(11):748-50. PubMed ID: 17096289 [No Abstract] [Full Text] [Related]
6. Estrogen receptor modulators: identification and structure-activity relationships of potent ERalpha-selective tetrahydroisoquinoline ligands. Renaud J; Bischoff SF; Buhl T; Floersheim P; Fournier B; Halleux C; Kallen J; Keller H; Schlaeppi JM; Stark W J Med Chem; 2003 Jul; 46(14):2945-57. PubMed ID: 12825935 [TBL] [Abstract][Full Text] [Related]
7. De novo design, synthesis, and evaluation of novel nonsteroidal phenanthrene ligands for the estrogen receptor. Schmidt JM; Mercure J; Tremblay GB; Pagé M; Kalbakji A; Feher M; Dunn-Dufault R; Peter MG; Redden PR J Med Chem; 2003 Apr; 46(8):1408-18. PubMed ID: 12672240 [TBL] [Abstract][Full Text] [Related]
8. QSAR of estrogen receptor modulators: exploring selectivity requirements for ER(alpha) versus ER(beta) binding of tetrahydroisoquinoline derivatives using E-state and physicochemical parameters. Mukherjee S; Saha A; Roy K Bioorg Med Chem Lett; 2005 Feb; 15(4):957-61. PubMed ID: 15686893 [TBL] [Abstract][Full Text] [Related]
9. Benzoxepin-derived estrogen receptor modulators: a novel molecular scaffold for the estrogen receptor. Lloyd DG; Hughes RB; Zisterer DM; Williams DC; Fattorusso C; Catalanotti B; Campiani G; Meegan MJ J Med Chem; 2004 Nov; 47(23):5612-5. PubMed ID: 15509159 [TBL] [Abstract][Full Text] [Related]
10. [Antiestrogens--benefits of estrogens without their disadvantages?]. Välimäki MJ; Tiitinen A Duodecim; 1998; 114(19):1885, 1887-8. PubMed ID: 11717742 [No Abstract] [Full Text] [Related]
11. Synthesis, biochemical properties and molecular modelling studies of organometallic specific estrogen receptor modulators (SERMs), the ferrocifens and hydroxyferrocifens: evidence for an antiproliferative effect of hydroxyferrocifens on both hormone-dependent and hormone-independent breast cancer cell lines. Top S; Vessières A; Leclercq G; Quivy J; Tang J; Vaissermann J; Huché M; Jaouen G Chemistry; 2003 Nov; 9(21):5223-36. PubMed ID: 14613131 [TBL] [Abstract][Full Text] [Related]
12. Benzopyrans are selective estrogen receptor beta agonists with novel activity in models of benign prostatic hyperplasia. Norman BH; Dodge JA; Richardson TI; Borromeo PS; Lugar CW; Jones SA; Chen K; Wang Y; Durst GL; Barr RJ; Montrose-Rafizadeh C; Osborne HE; Amos RM; Guo S; Boodhoo A; Krishnan V J Med Chem; 2006 Oct; 49(21):6155-7. PubMed ID: 17034120 [TBL] [Abstract][Full Text] [Related]
13. Discovery of potent ligands for estrogen receptor beta by structure-based virtual screening. Shen J; Tan C; Zhang Y; Li X; Li W; Huang J; Shen X; Tang Y J Med Chem; 2010 Jul; 53(14):5361-5. PubMed ID: 20553023 [TBL] [Abstract][Full Text] [Related]
14. Advances in the science of estrogen receptor modulation. Meegan MJ; Lloyd DG Curr Med Chem; 2003 Feb; 10(3):181-210. PubMed ID: 12570707 [TBL] [Abstract][Full Text] [Related]
16. The estrogen receptor: a model for molecular medicine. Jensen EV; Jordan VC Clin Cancer Res; 2003 Jun; 9(6):1980-9. PubMed ID: 12796359 [TBL] [Abstract][Full Text] [Related]
17. Benzopyrans as selective estrogen receptor beta agonists (SERBAs). Part 2: structure-activity relationship studies on the benzopyran scaffold. Richardson TI; Norman BH; Lugar CW; Jones SA; Wang Y; Durbin JD; Krishnan V; Dodge JA Bioorg Med Chem Lett; 2007 Jul; 17(13):3570-4. PubMed ID: 17485205 [TBL] [Abstract][Full Text] [Related]
18. [Selective estrogen receptor modulators: mechanisms of action and their tissue selectivity]. Azuma K; Inoue S Clin Calcium; 2004 Oct; 14(10):12-26. PubMed ID: 15577127 [TBL] [Abstract][Full Text] [Related]
19. Discovery of thiochroman and chroman derivatives as pure antiestrogens and their structure-activity relationship. Kanbe Y; Kim MH; Nishimoto M; Ohtake Y; Kato N; Tsunenari T; Taniguchi K; Ohizumi I; Kaiho S; Morikawa K; Jo JC; Lim HS; Kim HY Bioorg Med Chem; 2006 Jul; 14(14):4803-19. PubMed ID: 16580210 [TBL] [Abstract][Full Text] [Related]
20. Synthesis of 3-alkyl naphthalenes as novel estrogen receptor ligands. Fang J; Akwabi-Ameyaw A; Britton JE; Katamreddy SR; Navas F; Miller AB; Williams SP; Gray DW; Orband-Miller LA; Shearin J; Heyer D Bioorg Med Chem Lett; 2008 Sep; 18(18):5075-7. PubMed ID: 18722117 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]